Idiopathic Inflammatory Myopathy
Idiopathic Inflammatory Myopathy (IIM) is a rare autoimmune disease characterized by muscle inflammation, leading to muscle weakness and pain.
CAR T Cell Therapy for Severe Autoimmune Diseases
We are testing a new treatment using engineered immune cells for people with severe autoimmune diseases that haven't improved with standard therapies. This study aims to see if this approach can help manage their condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs, causing symptoms like joint pain, skin rashes, and fatigue.
Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic inflammatory disorder that primarily affects joints, leading to pain, swelling, and potential joint damage.
Systemic Sclerosis
Systemic Sclerosis (Scleroderma) is a rare autoimmune disease that causes hardening and tightening of the skin and connective tissues, affecting various organs.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Revmatologicky Ustav
Prague, Czechia
Fakultni Nemocnice V Motole
Oddeleni revmatologie deti a dospelych
Stodůlky, Czechia
Les Hopitaux Universitaires De Strasbourg
Rhumatologie
Eckbolsheim, France
Sponsor: Bristol-Myers Squibb Services Unlimited Company
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.